Influence of age on the pattern and outcome of external beam radiotherapy for clinically localized prostate cancer

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1319-1325

  Ogawa, Kazuhiko ^a,b   Nakamura, Katsumasa ^c   Onishi, Hiroshi ^d   Koizumi, Masahiko ^e   Sasaki, Tomonari ^c   Araya, Masayuki ^d   Miyabe, Yuuki ^f   Otani, Yuuki ^f   Teshima, Teruki ^f  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

Age; Elderly patients; Patterns of care study; Prostatic carcinoma; Radiation therapy

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; ESTROGEN; GONADORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; ELDERLY CARE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; INTERMETHOD COMPARISON; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645806134     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Severson RK, Montie JE, Porter AT and Demers RY: Recent trends in incidence and treatment of prostate cancer among elderly men. J Natl Cancer Inst 87: 532-534, 1995.
2. Lu-Yao GL and Yao SL: Population-based study of long-term survival in patients with clinically localized prostate cancer. Lancet 349: 906-910, 1997.
3. Mettlin CJ, Murphy GP, Cunningham MP and Menck HR: The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer 80: 1261-1266, 1997.
4. Huguenin PU, Bitteli M, Lutolf UM, Bernhard J and Glanzmann C: Localized prostate cancer in elderly patients: outcome after radiation therapy compared to matched young patients. Strahlenther Onkol 175: 544-548, 1999.
5. Geinitz H, Zimmermann FB, Thamm R, Schumertl A, Busch R and Molls M: 3D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol 76: 27-34, 2005.
6. Johansson JE, Adami HO, Andersson SO, Bergstorm R, Holmberg L and Krusemo UB: High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267: 2191-2196, 1992.
7. Albertsen PC, Fryback DG, Storer BE, Kolon TF and Fine J: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626-631, 1995.
8. McLaren DB, McKenzie M, Duncan G and Pickles T: Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma. Cancer 82: 342-348, 1998.
9. Steinberg GD, Bales GT and Brendler CB: An analysis of watchful waiting for clinically localized prostate cancer. J Urol 159: 1431-1436, 1998.
10. Albertsen PC, Hanley JA, Gleason DF and Barry MJ: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280: 975-980, 1998.
11. Health and Welfare Statistics Association. Health and Welfare Statistics in Japan. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare. Tokyo, Japan, pp. 38-46, 2004.
12. Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N and Inoue T: Radical radiotherapy for prostate cancer in Japan: a patterns of care study report. Jpn J Clin Oncol 33: 122-126, 2003.
13. Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Shioyama Y and Inoue T: Radiotherapy for localized hormone-refractory prostate cancer in Japan. Anticancer Res 24: 3141-3145, 2004.
14. Nakamura K, Ogawa K, Yamamoto Y, Sasaki T, Koizumi M, Teshima T and Inoue T: Trends in the practice of radiotherapy for localized prostate cancer in Japan: a preliminary patterns of care study report. Jpn J Clin Oncol 33: 527-532, 2003.
15. Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Teshima T and Inoue T: Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the 1999-2001 patterns of care process survey. Jpn J Clin Oncol 34: 29-36, 2004.
16. Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Inoue T and Teshima T: Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the changing trends in the patterns of care process survey between 1996-1998 and 1999-2001. Jpn J Clin Oncol 34: 131-136, 2004.
17. Ogawa K, Nakamura K, Onishi H, Sasaki T, Koizumi M, Shioyama Y, Komiyama T, Miyabe Y and Teshima T: Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey between 1996-1998 and 1999-2001. Anticancer Res 25: 3507-3512, 2005.
18. Ogawa K, Nakamura K, Onishi H, Sasaki T, Koizumi M, Shioyama Y, Komiyama T, Miyabe Y and Teshima T: Radical external beam radiotherapy for clinically localized prostate cancer in Japan: differences in the patterns of care between Japan and the United States. Anticancer Res 25: 3507-3513, 2005.
19. Hanks GE, Coia LR and Curry J: Patterns of care studies: past, present and future. Semin Radiat Oncol 7: 97-100, 1997.
20. Owen JB, Sedransk J and Pajak TF: National averages for process and outcome in radiation oncology: methodology of the patterns of care study. Semin Radiat Oncol 7: 101-107, 1997.
21. Teshima T: Patterns of care study in Japan. Jpn J Clin Oncol 35: 497-506, 2005.
22. ASTRO consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37: 1035-1041, 1997.
23. SAS Procedure Reference, version 6, 1st ed. Tokyo: SAS Institute in Japan, 1995.
24. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-81, 1958.
25. Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341-1346, 1995.
26. Suzuki H, Akakura K, Ueda T, Mikami K, Tobe T, Komiya A, Ichikawa T, Igarashi T and Ito H: Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or older. Eur Urol 41: 172-177, 2002.
27. Hanks GE, Hanlon A, Owen JB and Schultheiss TE: Patterns of radiation treatment of elderly patients with prostate cancer. Cancer 74: 2174-2177, 1994.
28. Villa S, Bedini N, Fallai C and Olmi P: External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: age is not a problem. Crit Rev Oncol Hematol 48: 215-225, 2003.
29. Alibhai SMH, Naglie G, Nam R, Trachtenberg J and Krahn MD: Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 21: 3318-3327, 2003.
30. Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES and Leibel SA: Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85: 2460-2468, 1999.
31. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, Yarnold J and Horwich A: Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet 353: 267-272, 1999.
32. De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, Ossterlinck W and DeNeve W: Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 60: 777-787, 2004.